LAST WEEK IN A NUTSHELL
- All 27 EU nations ratified the €750bn Next Generation EU package, opening the way to imminent delivery of their allocation of the fund package. Also, EU deficit rules remain suspended in 2022, given the time needed to reform the rules.
- In the US, the daily pace of vaccination continued to slow rapidly, with looming risk of missing the official target of providing one dose to 70% of adults by July 4th.
- In terms of data, Global PMI’s reached new highs in May, while euro zone inflation climbed to 2%, above the ECB's target for the first time since 2018.
- While negotiating to pass the infrastructure plan, President Biden offered to set a minimum 15% corporate tax rate to have Republicans agree on his spending plan.
- After G7 finance ministers and central bankers met over the week-end, the G7 summit in the UK will be the scene for the first international travel of US President Joe Biden.
- International tensions remain as Joe Biden signed a new executive order forbidding Americans to invest in 59 additional Chinese companies for security reasons.
- Markets will be eager to trade the US CPI data (4.7% expected) after the US job report was rather neutral (with a lower than expected figure of 559k job creations vs. better than expected 5.8% unemployment rate).
- The ECB will hold its policy meeting and publish new forecasts while the Fed will start to gradually and orderly reduce its corporate bonds and exchange-traded funds buying programme.
- Core scenario
- Our scenario of a global economic rebound, followed by a genuine growth-driven recovery, is unfolding. Recent market moves have put the focus on our investment convictions. The mechanical rebound of growth shall be followed by a transition supported by central banks and governments towards a sustainable recovery. The accumulated consumer savings will likely support a COVID-19 sensitive spending rebound, igniting hereby a positive feedback loop in the economic recovery.
- In the US, bond yields have stabilised for now but fiscal stimulus, large supply, economic recovery and vaccine rollout might support higher rates this year.
- In Europe, our central scenario assumes a comeback to growth trend by end-2021 and an implementation of the Next Generation EU plan in H2. Economic indicators reveal a large gap to be filled between services and manufacturing, as the latter has already started to benefit from the global economic rebound. Hence, the reflation trade could well move into a next stage as external demand surges and domestic demand is set to recover.
- Market views
- Financial markets are in an unique bullish macroeconomic environment but have recently shown a lack of leadership.
- The next move will be determined by the direction of rates, both nominal and real, which makes credibility of central banks essential to anchor inflation expectations.
- A more hawkish pricing for central bank policy impacts equities negatively but the sensitivity to revisions in the growth momentum are even more important. Therefore, we have exposure to investment themes which benefit from both accelerating growth and rising bond yields.
- We have exposure to recovery/re-opening related assets: Overweight equities vs. bonds, preference for ex-US to US equities, keep European and US banks, US and UK small and mid-caps, and exposure to commodities, GBP and NOK.
- Simultaneously, our core portfolio keeps the most resilient themes and countries.
- The duel virus vs vaccine. Vaccinations have the upper hand currently, but the appearance of new variants and the transition towards an endemic virus will raise new questions.
- Uncontrolled rise in bond yields. For the moment, central banks lack an exit plan from super-low interest rates. While bond yields have stabilised for now, inflation expectations could still point to fears from a demand shock and overheating growth.
- Geopolitical tensions. Revived tensions between China, and/or Russia, and the US can no longer be excluded, especially since the US has recently sanctioned Russia.
- Political uncertainty: The social divide is widening between losers and winners of the health crisis and several countries have elections coming up in the next 12 months starting with Germany which will elect a new Parliament in September.
RECENT ACTIONS IN THE ASSET ALLOCATION STRATEGY
The global context remains on a risk-on mode with supportive economic data and improving growth expectations fuelling sentiment. However, some major risks remain whether there are political, geopolitical, or policy-related. We are now living with the virus and while vaccination discrepancies will persist, economic volatility and negative market risk should abate gradually. While inflation fears are growing, we believe the current rise should remain temporary.
In that context, we remain underweight government bonds and keep a short duration in the euro zone and the US. On the equity side, we remain overall overweight equities and our strategy is geared towards reflation trades and long-term winning sectors. Despite an already strong catch-up, we also continue to see some upside on commodity prices. Given the risks described here, we keep some derivative protections.
CROSS ASSET STRATEGY
- 2021 is a recovery year which will positively carry over into 2022 and we anticipate a strong profit rebound. We prefer equities over bonds in this context.
- On the equity side, the unique bullish macroeconomic environment has cleared up some uncertainties causing a decline in volatility, while sectorial rotation towards value and cyclical sectors is still at play. Hence, our strategy is geared towards reflation trades and long-term winning sectors. Our multi-asset investments can be summarized as follows:
- We have exposure to assets related to the post-COVID rebound/recovery
Overweight equities vs. bonds, preference for ex-US equities.
Underweight government bonds, keeping a short duration. We focus on the source of the highest carry, i.e. emerging debt. We stay neutral US and European investment grade credit. Recently, we took profit on our relative trade on transatlantic sovereign spreads.
We have an exposure to rising commodity prices, via a basket that includes currencies, such as the AUD, the CAD and the NOK and we remain long GBP.
- Positive stance on Small caps
Current context is still supportive for ongoing rotation towards stocks geared to the recovery, a steepening of the yield curve and rising commodity prices.
We are buying small and mid-caps in the US, the UK and Latin America.
- Positive stance on Global Banks
We took partial profit after the strong rally on EMU banks and slightly decreased our global overweight exposure to the banking sector.
We keep an overweight stance on US banks, which could benefit from the yield curve steepening: We expect US10Y yields to hit 2% in the next 12 months
- Positive stance on long term growth thematics
Inclusion of secular megatrends to profit from long-term sustainable growth. The pandemic revealed that they are helpful in building a resilient portfolio. Environmental solutions, digitization and healthcare are our strongest thematic convictions.
Oncology and Biotech sectors reveal high growth potential.
Keep exposure to Tech and Innovation themes.
Purchase of consumer staples names (Food & Beverage sector).